SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-19-002262
Filing Date
2019-02-21
Accepted
2019-02-21 17:41:19
Documents
2
Period of Report
2019-02-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3297
2 WALSH UPDATED POA ex24walsh.txt EX-24.EX 24 3970
  Complete submission text file 0001179110-19-002262.txt   8803
Mailing Address ALLERGAN 5 GIRALDA FARMS MADISON NJ 07940
Business Address
WALSH MATTHEW M (Reporting) CIK: 0001269428 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36867 | Film No.: 19623113

Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Issuer) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations